يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"Roel J.W. van Kampen"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: MA Medische Oncologie (9)

    المصدر: Quality of Life Research, 29(12), 3363-3374. Springer, Cham
    Quality of Life Research

  5. 5

    المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie, Internal medicine, Hematology, CCA - Cancer Treatment and quality of life

    المصدر: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
    Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143

  6. 6
  7. 7
  8. 8

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, Health Services Research

    المصدر: Oncotarget
    Oncotarget, 8(45), 79223-79233. Impact Journals LLC

  9. 9

    المساهمون: RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Health Services Research, MUMC+: KIO Kemta (9), RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie

    المصدر: Oncologist, 21(5), 555-562. AlphaMed Press
    Oncologist, 21, 555-62
    Oncologist, 21, 5, pp. 555-62

  10. 10

    المساهمون: RS: CAPHRI School for Public Health and Primary Care, Pathologie, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - Oncology, Interne Geneeskunde, Algemene Heelkunde, Health Services Research, MUMC+: KIO Kemta (9), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Oncologist, 20, 8, pp. 856-63
    Oncologist, 20(8), 856-863. AlphaMed Press
    Oncologist, 20, 856-63